On November 18, 2011, the US Food and Drug Administration (US FDA) announced that
breast cancer indication for Avastin (bevacizumab) had been withdrawn after concluding that …

BACKGROUND: Inadequate access to useful scientifically accurate patient information is a
major cause of the inappropriate use of drugs resulting in serious personal injury and related …

Objectives To develop, implement, and assess a required patient safety course for second-year
doctor of pharmacy students. Design A patient safety course was developed that …

To measure the quality and usefulness of patient information leaflets distributed in Canadian
pharmacies, we compared the information contained in 3 leaflets distributed in Canada for …

In their clinical review of the management of atrial fibrillation, Lafuente-Lafuente and colleagues
mention the anticipated release of results comparing dronedarone with amiodarone. 1 …

Guillain-Barré syndrome (GBS), also known as acute idiopathic polyneuritis, is a type of
neuromuscular paralysis that has several variants. 1-3 These variants all share similar patterns …

In a communication dated July 7, 1997, Bayer Inc. informed Canadian pharmacists and
physicians of the completion of Health Canada’s review of calcium-channel blockers (CCBs). 1 …

To the Editor. A recent article1 by Dr. Jennifer Trujillo described an excellent curriculum
allowing pharmacy students in a third-year elective the ability to develop criticalthinking skills by …

Although the Glaser Pediatric Research Net-work Obesity Study Group1 appropriately calls
for more research on the long-term use of metformin, we are concerned that the door …

… Since many of Sukkari’s comments concern the editorial by Manson and Faich, we believe
it is the task of these physicians to respond. Although Manson and Faich have intermittently …